Biomechanical imbalance, trauma, and age-related degeneration often lead to chondral lesions which may lead to overt osteoarthritis over time. Such cartilage pathology is frequently accompanied by persistent pain and loss of normal joint function. As a result, patients who suffer from biologically active articular cartilage lesions are often unable to function in both high level activities and may exhibit compromised activities of daily living. The limited potential for self-regeneration of hyaline cartilage has led to the emergence of new technologies to solve this difficult clinical problem. In the event that the chondral lesion remains superficial to the subchondral bone, repair relies on the proliferation of surrounding cells and cells within the synovium as lesions are not exposed to the cellular and protein components of circulating blood. Lesions that include the subchondral bone and expose the marrow cavity rely on components therein for regeneration and repair. Cartilage synthesized without exogenous intervention usually resembles type 1 fibrous cartilage with inferior biomechanical properties when compared with native, hyaline cartilage replete with type 2 collagen. 1 Treatment of arthritis and chondral lesions includes alleviation of pain and return of function through pharmacologic intervention and/or attempts at cartilage reparative, restorative and reconstructive options. 2 Systemic pharmacologic treatments for degenerative arthritis aim to reduce inflammation and decrease associated pain. Topical treatments include nonsteroidal antiinflammatories such as diclofenac gels that isolate the pathologic joint localizing treatment and decreasing the possibility of systemic side effects. Traditional injectables such as cortisone injections and viscosupplementation have been found to decrease pain for short and medium time periods. Corticosteroids have been shown to provide a 30 to 50% decrease in pain which is most evident in the first 4 weeks after treatment. 3 Viscosupplementation with various formulations and molecular weights of hyaluronic acid has been shown to impart similar, but longer lasting results. 4 It is our purpose to discuss the nontraditional and innovative nonsurgical treatments for articular cartilage pathology. Weight loss, physical therapy, oral antiinflammatories, and corticosteroids are, at present, the standard of care for conservative treatment modalities for arthritis. The use of biologic injectables such as growth factors, platelet rich plasma (PRP), autologous conditioned serum (ACS), and stem cell therapy are currently under investigation and will be the present focus. Although the clinical evidence supporting the use of these modalities is sparse, their potential is clear as is the need for their continued development.
Keywords► cartilage repair ► osteoarthritis ► platelet rich plasma ► growth factor ► mesenchymal stem cells
AbstractBiomechanical imbalance, trauma, and age-related degeneration often result in chondral lesions, which may lead to overt osteoarthritis over time. S...